Home
About
FAQ
History (29)
From rehabilitation to recovery: protocol for a randomised controlled trial evaluating a goal-based intervention to reduce depression and facilitate participation post-stroke.
Curative potential of chemoimmunotherapy in diffuse large B cell lymphoma with hepatic and/or renal dysfunction.
Complications of Methamphetamine Use in Orthopaedic Trauma.
A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration.
Position Paper on the Reporting of Norepinephrine Formulations in Critical Care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Results (37)
More Search Options
Sort
Query Relevance
Name (A-Z)
Name (Z-A)
Institution (A-Z)
Institution (Z-A)
Show
(choose columns)
Faculty Rank
Name
Institution
Why
James C. Eisenach MD
Wake Forest School of Medicine
Why?
Mario D. Boada Donoso PhD
Wake Forest School of Medicine
Why?
Douglas G. Ririe MD, PhD, MHA
Wake Forest School of Medicine
Why?
Mustapha A. Ezzeddine MD
Wake Forest School of Medicine
Why?
Christopher M. Peters PhD
Wake Forest School of Medicine
Why?
Adrian W. Laxton MD
Wake Forest School of Medicine
Why?
Chuanyao Tong MD
Wake Forest School of Medicine
Why?
Sara Jones PhD
Wake Forest School of Medicine
Why?
Terrence R. Stanford PhD
Wake Forest School of Medicine
Why?
Robert W. Hurley MD, PhD
Wake Forest School of Medicine
Why?
Yusuke Shiozawa MD, PhD
Wake Forest School of Medicine
Why?
Debra I. Diz PhD
Wake Forest School of Medicine
Why?
Barry E. Stein PhD
Wake Forest School of Medicine
Why?
Thomas J. Martin PhD
Wake Forest School of Medicine
Why?
Ji Hyun Kim PhD
Wake Forest School of Medicine
Why?
Per Page
15
25
50
100
Page
of 3
Next
Prev
Search Criteria
Ganglia
Click "Why?" to see why a person matched the search.
Search Options
Modify Search
Search Other Institutions